- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03010852
Focused Incentive Spirometry Monitoring to Reduce Postoperative Oxygen Therapy and Respiratory Complications After Bariatric Surgery
February 11, 2021 updated by: University of Colorado, Denver
Postoperative (PO) hypoventilation, atelectasis and hypoxemia after bariatric surgery are common and multifactorial, contributing to prolonged oxygen (O2) therapy after surgery and even at hospital discharge.
Incentive spirometry (IS) is recommended postoperatively but its success in preventing postoperative atelectasis and hypoxemia (POH) heavily depends on patient compliance with IS effort and frequency.
The investigators hypothesize that a focused education preoperatively on IS for POH and intensive monitoring of patient compliance with IS therapy in the early postoperative period shortens postoperative oxygen therapy, decreases POH episodes, and improves respiratory outcomes after bariatric surgery, compared to patients receiving standard of care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients having planned elective bariatric surgery at University of Colorado Hospital
Exclusion Criteria:
- Emergency procedure
- Oxygen therapy within the previous 30 days
- Smoking within the previous 30 days
- Inability or refusal to provide consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard of care incentive spirometer
Patients in the SOC cohort will not receive the preoperative education and only one postoperative visit per day to collect their self-reported use of IS, if prescribed, and respiratory symptoms but avoiding increasing their awareness of POH, O2 therapy and IS.
|
|
Experimental: Focused incentive spirometer education and monitoring
One of the study investigators will meet eligible patients in the preoperative visit to the UCH Weight Loss Surgery clinic, inform and consent the patient and introduce the first education on IS therapy, highlighting its possible benefits and the importance of compliance (patient's inspiratory effort and frequency).
This IS education will be repeated in the preoperative area immediately before surgery.
The site will then follow the patient postoperatively.
The site will directly check on the patient in the PACU and later in his/her hospital room at least 3 times a day during the first 3 days or sooner if their O2 therapy is discontinued for 2h.
During these PO check ups The site will reinforce the IS use, monitor the patient's performance of IS and ask him/her about other respiratory symptoms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Frequency of at least one episode of moderate/severe hypoxemic event
Time Frame: During first post operative day
|
During first post operative day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of postoperative oxygen therapy
Time Frame: Up to 7 days after surgery
|
The duration of postoperative oxygen therapy will be evaluated from the arrival to the post-anesthesia care unit to successful discontinuation of oxygen therapy lasting greater than 2 hours.
|
Up to 7 days after surgery
|
Presence of postoperative oxygen therapy and postoperative hypoxemic events
Time Frame: Up to 7 days after surgery
|
The development of postoperative hypoxemic events will be evaluated from the initiation of post-operative oxygen therapy through hospital discharge.
|
Up to 7 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ana Fernandez-Bustamante, M.D., Ph.D., University of Colorado, School of Medicine - Department of Anesthesology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Actual)
August 1, 2020
Study Completion (Actual)
December 1, 2020
Study Registration Dates
First Submitted
December 7, 2016
First Submitted That Met QC Criteria
January 3, 2017
First Posted (Estimate)
January 5, 2017
Study Record Updates
Last Update Posted (Actual)
February 12, 2021
Last Update Submitted That Met QC Criteria
February 11, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 16-1268
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
N/A IPD will not be shared with other researchers
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Complication
-
Asst Melegnano e MartesanaEnrolling by invitationMortality | Nephrotoxicity | Respiratory Complication | Neurological Complication | Surgical Complication | Metabolic Complication | Cardiovascular ComplicationItaly
-
Eske Kvanner AasvangCompletedComplication of Surgical Procedure | Respiratory Complication | Complication of Anesthesia | Circulatory; ComplicationsDenmark
-
Uppsala UniversityNot yet recruitingMechanical Ventilation Complication | Respiratory Complication | Neurological Complication
-
Assiut UniversityCompletedRespiratory Complication | Bypass ComplicationEgypt
-
Instituto de Cardiologia do Rio Grande do SulCompletedRespiratory ComplicationBrazil
-
Medtronic - MITGTerminatedRespiratory ComplicationGermany
-
Vital USA, Inc.Clinimark, LLCCompleted
-
Sangjin ParkCompletedRespiratory ComplicationKorea, Republic of
-
Memorial Health University Medical CenterUnknownRespiratory ComplicationUnited States
-
Sangjin ParkCompleted
Clinical Trials on Focused incentive spirometer education and monitoring
-
Riphah International UniversityRecruitingInterstitial Lung DiseasePakistan
-
Kessler FoundationU.S. Department of EducationCompletedSpinal Cord InjuryUnited States
-
Chang Gung Memorial HospitalCompletedRib Fractures | Hemothorax; Traumatic | Rib Trauma
-
Northwell HealthCompleted
-
King Saud UniversityCompletedPost Coronary Artery Bypass GraftingSaudi Arabia
-
Cairo UniversityCompletedPneumonia Hospital AcquiredEgypt
-
Singapore General HospitalNational University Hospital, Singapore; National University Polyclinics, Singapore and other collaboratorsActive, not recruitingDiabetes Mellitus, Type 2 | Flash Glucose MonitoringSingapore
-
Carilion ClinicMerck Sharp & Dohme LLCCompletedCommunity Acquired PneumoniaUnited States
-
Sengkang General HospitalUniversiti Putra Malaysia; University of Malaya; Khoo Teck Puat Hospital; Singapore... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes Complications | FastingSingapore
-
Sengkang General HospitalSingapore Clinical Research Institute; SingHealth PolyclinicsCompletedDiabetes Mellitus | Diabetes Complications | FastingSingapore